Wednesday, December 22, 2021

Novartis commits $1.5B to acquire eye disease gene therapy biotech Gyroscope - MedCity News

Novartis is acquiring gene therapy developer Gyroscope Therapeutics and its lead program, a potential treatment for the vision loss disorder ...
https://www.google.com/url?rct=j&sa=t&url=https://medcitynews.com/2021/12/novartis-commits-1-5b-to-acquire-eye-disease-gene-therapy-biotech-gyroscope/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHaV3XtjjW5sU35mx-nwHjNZKPNxg

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...